Search

Displaying results 4231 - 4240 of 8412 in total
  1. Drug

    Glycerol phenylbutyrate

    go.drugbank.com/drugs/DB08909
    ApprovedInvestigational

    Glycerol phenylbutyrate is a nitrogen-binding agent. Chemically, it is a triglyceride in which three molecules of phenylbutyrate are linked to a glycerol backbone. FDA approved on February 1, 2013.

    Categories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP2D6 Inhibitors
  2. Drug

    Epitizide

    go.drugbank.com/drugs/DB13989
    Experimental

    Epitizide is an agent, commonly found in combination [triamterene], used to produce diuresis.

  3. Drug

    ABT-737

    go.drugbank.com/drugs/DB17023
    Experimental

    An inhibitor of members of the Bcl‑2 family of apoptosis regulators.[A252977]

  4. Drug

    APR-548

    go.drugbank.com/drugs/DB17546
    Investigational

    APR-548 is an analog of [eprenetapopt] and a reactivator of mutant p53.

  5. Drug

    INO-4995

    go.drugbank.com/drugs/DB17834
    Experimental

    INO-4995 is an inositol tetrakisphosphate analog being investigated for Cystic Fibrosis.[A259781]

  6. Drug

    HMI-204

    go.drugbank.com/drugs/DB18338
    Experimental

    HMI-204 is an adeno-associated virus serotype HSC15 expressing human arylsulfatase A

  7. Drug

    Heat stable ricin vaccine

    go.drugbank.com/drugs/DB18477
    Investigational

    Heat stable ricin vaccine is an alum-adjuvanted, heat stable recombinant subunit vaccine.

  8. Drug

    VGB-R04

    go.drugbank.com/drugs/DB18615
    Investigational

    VGB-R04 is an adeno-associated viral vector delivering human FIX Padua gene.

  9. Drug

    Zedenoleucel

    go.drugbank.com/drugs/DB18639
    Investigational

    MT-401 is an allogeneic multi-tumor-associated antigen-specific T-cell therapy.

  10. Drug

    ABBV-706

    go.drugbank.com/drugs/DB18710
    Investigational

    ABBV-706 is an antibody-drug conjugate that is anti-SEZ6.[L49156,L49161]